EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Karen M L Tan iD, Jolene Chee, Kezlyn L M Lim, Maisie Ng, Min Gong, Jia Xu, Felicia Tin, Padmapriya Natarajan, Bee Lan Lee, Choon Nam Ong, Mya Thway Tint, Michelle Z L Kee und 9 weitere

Nutrients · 2023

DOI: 10.3390/nu15102325 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Karen M L Tan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Singapore Institute for Clinical Sciences, Agency for Science Technology and Research Singapore, Singapore 117609, Singapore. Hauptthemen laut MEDLINE: Vitamin A, Beta-Cryptoxanthin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DSM Nutritional Products, DSM Nutritional Products Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: β-cryptoxanthin is a dietary carotenoid for which there have been few studies on the safety and pharmacokinetics following daily oral supplementation.

Methods

90 healthy Asian women between 21 and 35 years were randomized into three groups: 3 and 6 mg/day oral β-cryptoxanthin, and placebo. At 2, 4, and 8 weeks of supplementation, plasma carotenoid levels were measured. The effects of β-cryptoxanthin on blood retinoid-dependent gene expression, mood, physical activity and sleep, metabolic parameters, and fecal microbial composition were investigated. Results: β-cryptoxanthin supplementation for 8 weeks (3 and 6 mg/day) was found to be safe and well tolerated. Plasma β-cryptoxanthin concentration was significantly higher in the 6 mg/day group (9.0 ± 4.1 µmol/L) compared to 3 mg/day group (6.0 ± 2.6 µmol/L) (p < 0.03), and placebo (0.4 ± 0.1 µmol/L) (p < 0.001) after 8 weeks. Plasma all-trans retinol, α-cryptoxanthin, α-carotene, β-carotene, lycopene, lutein, and zeaxanthin levels were not significantly changed. No effects were found on blood retinol-dependent gene expression, mood, physical activity and sleep, metabolic parameters, and fecal microbial composition.

Conclusions

Oral β-cryptoxanthin supplementation over 8 weeks lead to high plasma concentrations of β-cryptoxanthin, with no impact on other carotenoids, and was well tolerated in healthy women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin ABeta-CryptoxanthinHumansFemaleCarotenoidsbeta CaroteneLuteinZeaxanthinsDietary Supplements

Stichwörter der Autor:innen

Asian womencarotenoidsfecal microbiomegene expressionmoodphysical activity

Substanzen

Vitamin ABeta-CryptoxanthinCarotenoidsbeta CaroteneLuteinZeaxanthins

Autor:innen und Institutionen

  • Singapore Institute for Clinical Sciences, Agency for Science Technology and Research Singapore, Singapore 117609, Singapore.
  • Department of Laboratory Medicine, National University Hospital, Singapore 119074, Singapore.
  • Bioinformatics Institute, Agency for Science Technology and Research Singapore, Singapore 138671, Singapore.
  • Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.
  • Human Potential Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.

ORCID-Profile: Karen M L Tan, David Cameron-Smith

Förderung

  • DSM Nutritional Products
  • DSM Nutritional Products Ltd.

Zitieren

APA

Tan, K. M. L., Chee, J., Lim, K. L. M., Ng, M., Gong, M., Xu, J., Tin, F., Natarajan, P., Lee, B. L., Ong, C. N., Tint, M. T., Kee, M. Z. L., Müller-Riemenschneider, F., Gluckman, P. D., Meaney, M. J., Kumar, M., Karnani, N., Eriksson, J. G., Nandanan, B., …, & Cameron-Smith, D. (2023). Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Nutrients. https://doi.org/10.3390/nu15102325

Vancouver

Tan KML, Chee J, Lim KLM, Ng M, Gong M, Xu J, et al. Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Nutrients. 2023. doi:10.3390/nu15102325

BibTeX
@article{Tan2023,
  author = {Tan, Karen M L and Chee, Jolene and Lim, Kezlyn L M and Ng, Maisie and Gong, Min and Xu, Jia and Tin, Felicia and Natarajan, Padmapriya and Lee, Bee Lan and Ong, Choon Nam and Tint, Mya Thway and Kee, Michelle Z L and Müller-Riemenschneider, Falk and Gluckman, Peter D and Meaney, Michael J and Kumar, Mukkesh and Karnani, Neerja and Eriksson, Johan G and Nandanan, Bindu and Wyss, Adrian and Cameron-Smith, David},
  title = {Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15102325}
}
Kostenlos starten →